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The vaccinia virus E3 gene encodes a 190-amino acid double-stranded (ds) RNA-binding protein that antagonizes cellular
antiviral response pathways triggered by dsRNA and interferon. The physical and functional properties of the E3 protein
were determined using recombinant E3 produced in bacteria and purified to homogeneity. We show by sedimentation and
chemical crosslinking that E3 is a dimer in solution at high ionic strength. E3 self-associates to form higher order oligomers
as ionic strength is reduced from 1 to 0.1 M NaCl. Structure probing by limited proteolysis suggests that E3 consists of
amino- and carboxyl-terminal domains separated by a trypsin-sensitive bridge at residues Lys-92 and Arg-95. The carboxyl-
domain of E3 contains a conserved dsRNA binding motif (dsRBM) found in many other proteins that interact with dsRNA.
That the C-terminal domain per se binds to dsRNA was verified by studies of recombinant E3(100–190) purified from
bacteria. The affinity of the C-terminal domain for dsRNA was comparable to that of the full-length E3 protein (KD  7 to
9 nM). E3(100–190) did not bind to DNA–DNA duplexes or to DNA–RNA hybrids, suggesting that the dsRBM specifically
recognizes an A-form helix. E3(100–190) is a dimer in solution; however, unlike the full-sized E3 protein, E3(100–190) does
not form higher order multimers at low ionic strength. q 1996 Academic Press, Inc.
INTRODUCTION the protein (Chang et al., 1992). Two E3 gene products
are detected at early times after vaccinia infection, a 25-
Vaccinia and other poxviruses encode a battery of pro-
kDa polypeptide representing the full-length product of
teins that antagonize the host response to virus infection.
the E3 open reading frame (190 amino acids) and a 20-
Among these are the vaccinia K3 and E3 proteins, which
kDa polypeptide that is truncated at the N-terminus byact within the infected cell to override the inhibition of
virtue of translation initiation from the first downstreamprotein synthesis induced by interferon (Beattie et al.,
start codon (at Met-38) (Yuwen et al., 1993). Both forms1991; Chang et al., 1992). K3 and E3 both target the
are capable of binding to dsRNA in vitro.cellular double-stranded RNA-dependent protein kinase
A recombinant vaccinia virus deleted at the E3 locusPKR. The K3 protein is an eIF-2a homologue that acts
displays two distinctive phenotypes relative to the wild-as a pseudosubstrate for PKR, effectively sparing the
type virus: (i) restricted host range, and (ii) sensitivity tocellular pool of translation initiation factor from inactiva-
interferon, seen at the level of interferon inhibition oftion by PKR (Beattie et al., 1991; Carroll et al., 1993; Beat-
protein synthesis and interferon induction of RNA degra-tie et al., 1995). E3 is a double-stranded RNA binding
dation (Beattie et al., 1995). Apparently, the E3 proteinprotein that inhibits the dsRNA-dependent autophos-
suppresses both arms of the dsRNA-dependent inter-phorylation of PKR, essentially by sequestering the
feron response—the protein synthesis shutoff mediateddsRNA activator (Chang et al., 1992).
by PKR and the activation of the 2-5A synthetase path-A vaccinia-induced inhibitor of PKR autophosphoryla-
way. Genetic complementation of the phenotype of thetion was reported initially in 1984 (Whittaker-Dowling and
E3-deletion virus by transient expression of the wild-typeYoungner, 1984; Rice and Kerr, 1984). The assignment
and mutated versions of the E3 protein reveals a strictof this function to the E3 gene product was made by
correlation between in vivo rescue and the ability of theJacobs and co-workers, who purified by dsRNA affinity
mutant proteins to bind to dsRNA in vitro (Chang et al.,chromatography a 25-kDa dsRNA binding protein with
1995). Remarkably, the host–range and interferon-sensi-kinase-inhibitory activity (Watson et al., 1991) and then
tive phenotypes of the E3-deletion virus can also be re-mapped the gene after obtaining a peptide sequence of
versed by expression of a dsRNA binding protein en-
coded by an unrelated virus, i.e., the reovirus S4 protein
1 This work was supported by Grant GM42498 from the National (Beattie et al., 1995). These findings argue that the biolog-Institutes of Health.
ical activity of E3 derives primarily, if not exclusively, from2 To whom correspondence and reprint requests should be ad-
dressed. its capacity to bind to dsRNA.
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The physical properties of the E3 protein have not been Expression and purification of recombinant E3 protein.
A 1-liter culture of E. coli BL21(DE3)/pET-E3 was growncharacterized beyond the observation that gel filtration of
an S-100 fraction of vaccinia-infected cells yielded a peak at 377 in LB medium containing 0.15 mg/ml ampicillin
until the A600 reached 0.45. IPTG was then added to 0.4of immunoreactive E3 protein with an estimated size of
66 kDa (Watson et al., 1991). It was not clear whether mM final concentration and incubation was continued at
377 for 4 hr. Cells were harvested by centrifugation andthis reflected the formation of an E3 multimer or the asso-
ciation of E3 with other viral or cellular proteins. Studies the pellet was stored at0807. All subsequent procedures
were performed at 47. Thawed bacteria were resus-to date of the RNA binding properties of E3 have been
largely qualitative in design. E3 binds to poly(rI)–poly(rC) pended in 100 ml of 50 mM Tris HCl, pH 7.5, 0.15 M
NaCl, 1 mM EDTA, 10% sucrose and lysed by additionagarose (Watson et al., 1991). Hence, most tests of func-
tion have involved synthesis of [35S]methionine-labeled of lysozyme (0.2 mg/ml final concentration) and 0.1% Tri-
ton X-100. The lysate was centrifuged at 18,000 rpm forE3 protein from synthetic mRNA using an in vitro transla-
tion system, followed by adsorption of the labeled trans- 45 min in a Sorvall SS34 rotor. The pellet, which con-
tained most of the expressed E3 protein, was resus-lation products to poly(rI)–poly(rC) agarose, elution of
the bound material with SDS, and analysis of the un- pended using a Dounce homogenizer in 50 ml of 50 mM
Tris HCl, pH 7.5, 0.15 M NaCl, 1 mM EDTA, 10% sucrose,bound and bound fractions by SDS–PAGE (Chang et al.,
1992; Chang and Jacobs, 1993; Yuwen et al., 1993). Using 0.1% Triton X-100. The centrifugation step was repeated
and the pelleted material was resuspended in 25 ml ofthis assay, it was found that C-terminal segments of the
E3 protein from residues 84–190 (Chang and Jacobs, buffer A (50 mM Tris HCl, pH 8.0, 1 mM EDTA, 2 mM
DTT, 10% glycerol, 0.1% Triton X-100) containing 0.5 M1993) or from 94–190 (Yuwen et al., 1993) could bind to
poly(rI)–poly(rC), whereas C-terminal deletions reduced NaCl. This suspension was centrifuged again. The re-
combinant E3 protein was partially soluble in 0.5 M NaClor abrogated RNA binding (Chang and Jacobs, 1993).
Hence, the C-terminal portion was necessary and suffi- and could be recovered in the 0.5 M NaCl supernatant
along with residual lysozyme. The 0.5 M NaCl pellet,cient for RNA binding. This region of E3 includes a con-
served dsRNA binding motif found in many other proteins which still contained substantial E3, was resuspended
in buffer A containing 1 M NaCl. The E3 protein wasthat interact with dsRNA (St Johnston et al., 1992; McCor-
mack et al., 1992; Chang and Jacobs, 1993). soluble in 1 M NaCl and was recovered in the superna-
tant fraction after centrifugation. A second extraction ofIn the present study, we report a physical and func-
tional characterization of recombinant E3 protein ex- the 1 M NaCl pellet with buffer A containing 1 M NaCl
enhanced the yield of soluble E3 protein. The two 1 Mpressed in bacteria and purified to homogeneity. We as-
sess the oligomerization state of the protein as a function NaCl supernatants were combined (25 ml, containing 45
mg of protein) and adjusted to 0.2 M NaCl by five-foldof ionic strength, delineate structural domains by limited
proteolysis, and assay RNA binding to protein in solution. dilution with buffer A. This material was applied to a 10-
ml column of phosphocellulose that had been equili-Also presented is a physical and functional characteriza-
tion of the purified recombinant C-terminal domain of E3 brated in buffer A containing 0.2 M NaCl. The column
was washed with the same buffer and then eluted step-that includes the dsRNA binding motif.
wise with 0.3, 0.4, 0.5, and 1.0 M NaCl in buffer A. The
MATERIALS AND METHODS E3 protein was retained on the column and recovered in
the 0.4 M NaCl eluate (25 mg of protein). This fractionT7-based vector for expression of E3 in bacteria. Oligo-
nucleotide primers complementary to the 5* and 3* ends was mixed with an equal volume of buffer A and then
applied to a 10-ml heparin agarose column that had beenof the E3 gene and containing restriction sites for NdeI
and BamHI, respectively, were used to amplify the E3 equilibrated with 0.2 M NaCl in buffer A. The E3 protein
was retained on the column and was eluted with bufferopen reading frame from a pBR-based plasmid con-
taining the vaccinia genomic HindIII E fragment. The se- A containing 0.4 M NaCl (15 mg of protein). The heparin
agarose E3 preparation was stored at 0807 and thawedquence of the 5* flanking primer was 5*-GTTAGTTCT-
CTCTACATATGTCTAAAATCTATA; the 3* flanking primer on ice prior to use. Protein concentrations were deter-
mined using the Bio-Rad dye-binding assay, with bovinewas 5*-CTACTAACTGTTATGGATCCCTAGAATCAGAATC.
PCR was carried out using Taq DNA polymerase. The serum albumin as a standard.
Expression and purification of E3(100–190). A trun-PCR reaction products were digested with endonucle-
ases NdeI and BamHI, then inserted into T7-based ex- cated version of the E3 gene was amplified by PCR using
the 3* primer described above and a 5* primer designedpression plasmid pET3c to yield pET-E3. It was confirmed
by dideoxy sequencing that the nucleotide sequence of to introduce an NdeI restriction site at the codon for
amino acid residue 99. The PCR product was digestedthe E3 insert in pET-E3 was identical to that of the wild-
type vaccinia E3 gene. pET-E3 was introduced by electro- with NdeI and BamHI, then inserted into a modified pET-
based expression vector such that the E3 coding se-poration into Escherichia coli BL21(DE3).
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quence from amino acid Ser-100 to C-terminal residue activity of the GTP in the transcription reaction. An an-
nealing reaction mixture (50 ml) containing 15 mM TrisPhe-190 was fused in-frame to a 5* leader encoding a
customized His-tag, Met–Gly–Ser–His–His–His–His – HCl, pH 7.4, 0.4 M NaCl, 2.5 mM EDTA, 25 pmol of the
155-nt strand, and 5 pmol of the 39-nt strand was boiledHis–His–Ser–Gly–His– Met. Dideoxy sequencing of the
insert verified that no mutations had been introduced for 5 min, then incubated at 687 for 5 min, followed by
slow-cooling to room temperature. The single-strandedduring the PCR and cloning operations. An NcoI–BamHI
fragment containing the His-E3(100–190) coding region tails of the RNA hybrids, as well as the excess unhybrid-
ized 155-nt RNA strands, were digested by treatment withwas transferred to the T7-based expression vector
pET21d (Novagen) to yield pET-His-E3(100–190). In this RNase A (50 mg/ml) for 60 min at 157. The reaction was
terminated by addition of SDS. The RNA was extractedcontext, basal expression of the plasmid-encoded pro-
tein in E. coli BL21(DE3) is repressed by a lac operator with phenol–chloroform, precipitated with ethanol, and
resuspended in 10 mM Tris HCl, pH 8, 0.15 M NaCl, 1sequence situated upstream of the E3 insert.
Protein expression was induced by addition of 0.4 mM mM EDTA for use in RNA binding assays.
Gel mobility shift assay of dsRNA binding. ReactionIPTG to a 1-liter culture of BL21(DE3)/pET-His-E3(100 –
190), as described above for the full-length E3 protein. mixtures (10 ml) containing 50 mM Tris HCl, pH 8.0, 40
mM NaCl, 1 mM EDTA, 2 mM DTT, 0.1% Triton X-100,The cell pellet was suspended in 50 mM Tris HCl, pH
7.5, 0.15 M NaCl, 10% sucrose, and lysed by treatment 5% glycerol, 20 fmol of 32P-labeled dsRNA, and E3 or
E3(100–190) protein as specified were incubated for 15with lysozyme and Triton X-100. Insoluble material recov-
ered after centrifugation was resuspended in 5 ml of min at 257. Protein–RNA complexes were resolved from
free RNA by electrophoresis through a native 4% poly-buffer B (50 mM Tris HCl, pH 8.0, 10% glycerol, 0.1%
Triton X-100) containing 1 M NaCl. Soluble and insoluble acrylamide gel (80:1 acrylamide:bisacrylamide) con-
taining 45 mM Tris-borate, 1.2 mM EDTA. The gel wasfractions were separated by centrifugation. After a sec-
ond extraction of the pellet with 1 M NaCl in buffer B, the run at 150 V for 35 min. Radiolabeled species were visu-
alized by autoradiography of the dried gel. Where indi-two 1 M NaCl supernatant fractions containing soluble
E3(100–190) were combined (10 ml, 4 mg of protein). cated, the gels were scanned using a FUJIX BAS1000
Bio-Imaging Analyzer. In order to estimate binding affin-This material was applied to a 2-ml column of Ni–NTA–
agarose (Qiagen) equilibrated with buffer B containing ity, the fraction of unbound RNA (expressed as percent-
age of the total labeled RNA) was plotted as a function1.0 M NaCl. The column was washed with 0.5 M NaCl
in buffer B and eluted stepwise with 5, 100, and 500 mM of the concentration of input E3 protein. Dissociation con-
stants were calculated as described by Riggs et al.imidazole in buffer B containing 0.5 M NaCl. The E3(100 –
190) protein was recovered in the 500 mM imidazole (1970).
Peptide sequencing. The polypeptide products of aeluate. This fraction (1.5 mg of protein) was dialyzed
against buffer A containing 0.5 M NaCl. The dialysate limited tryptic digestion of 5 mg of purified recombinant
E3 protein were resolved by SDS–PAGE (15% polyacryl-was stored at 0807.
Preparation of dsRNA. A radiolabeled 39-bp dsRNA amide). The gel was soaked in 100 ml of electroblotting
buffer (10 mM CAPS (3-[cyclohexylamino]-1-propanesul-ligand was formed by hybridizing two complementary
RNA strands synthesized in vitro. A 39-nt RNA was tran- fonic acid), pH 9, 10% methanol) for 5 min at room temper-
ature. Polypeptides were transferred to a PVDF mem-scribed by T7 RNA polymerase from a pBluescript II-KS
DNA template that had been linearized with XbaI. The brane (Bio-Rad) in electroblotting buffer by electrophore-
sis at 20 V for 45 min using a Bio-Rad Trans-Blot SDpredicted sequence of the run-off transcript is 5*-GGG-
CGAAUUGGAGCUCCACCGCGGUGGCGGCCGCUC- semidry transfer cell. The membrane was rinsed with
water, then with methanol. The membrane was stainedUAG. A 155-nt RNA strand, which included a 39-nt se-
quence complementary to the 39 mer, was synthesized with 0.1% Coomassie blue in 40% ethanol/1% acetic acid
for 1 min, followed by destaining with 50% methanol andby T3 RNA polymerase from pBluescript II-KS linearized
with BssH1. Transcription reactions contained [a32P]GTP rinsing with water at 47 for 16 hr. The membrane was
air-dried and slices containing individual proteolyticplus unlabeled ATP, CTP, and UTP. The specific activity
of the [a32P]GTP used for synthesis of the 39-mer was products were excised. Automated sequencing of the
immobilized polypeptide was performed using a modified100-fold higher than that used during synthesis of the
155-mer strand. The reaction products were extracted Model 477A microsequencer (Applied Biosystems).
with phenol:chloroform, ethanol precipitated, and electro-
phoresed through a 10% denaturing polyacrylamide gel. RESULTS
The run-off transcripts were localized by autoradiogra-
phy, eluted from an excised gel slice, then ethanol precip- Expression and purification of recombinant E3 protein.
To obtain E3 in quantity sufficient for physical and func-itated and resuspended in water. The molar concentra-
tion of labeled RNA was calculated based on specific tional characterization, we expressed recombinant pro-
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FIG. 1. Expression and purification of recombinant E3 protein. (A) Induction of E3 expression in E. coli BL21(DE3)/pET-E3 was seen by SDS–
PAGE analysis of whole cell lysates of uninduced (lane 1) and IPTG-induced (lane 2) bacteria. The E3 polypeptide (denoted by the arrow at right)
was recovered primarily in the insoluble pellet fraction (lane 4) rather than the soluble supernatant (lane 3). The protein was partially solubilized
by extraction of the pellet with 0.5 M NaCl (lane 5) and reextraction with 1.0 M NaCl (lane 6). The protein was purified by phosphocellulose
chromatography (lane 7; 0.4 M NaCl phosphocellulose fraction) and heparin agarose chromatography (lane 8; 0.4 M NaCl eluate) as described
under Materials and Methods. The protein samples were electrophoresed through a 15% polyacrylamide gel in 0.1% SDS. Polypeptides were
visualized by staining with Coomassie blue dye. The positions and sizes (in kDa) of marker proteins are indicated on the left. (B) Binding of E3 to
poly(rI)–poly(rC) agarose. The heparin agarose E3 preparation (1 mg) was applied to a 0.5-ml column of poly(rI)–poly(rC) agarose (Pharmacia) that
had been equilibrated at room temperature in buffer A containing 0.5 M NaCl. The column was washed with the same buffer, eluted stepwise with
buffer A containing 1.0, 1.5, and 2.0 M NaCl (0.75 ml per step), then eluted stepwise under denaturing conditions with buffer A containing 1 and
2% SDS (0.75 ml per step). Aliquots of the input heparin agarose fraction (HA), the poly(rI)–poly(rC) agarose flow-through (FT), the NaCl eluates,
and the SDS eluates were electrophoresed through a 15% polyacrylamide gel in 0.1% SDS. A Coomassie-blue-stained gel is shown. The positions
and sizes (in kDa) of marker proteins are indicated on the left.
tein in bacteria. An expression vector was constructed 1 M NaCl yielded a virtually homogeneous preparation of
E3 (Fig. 1A, lane 6). The E3 protein was soluble uponsuch that the coding sequence of the vaccinia virus E3
gene was placed under the transcriptional control of a dilution of the sample to 0.2 M NaCl and remained so
during further purification via phosphocellulose (Fig. 1A,T7 RNA polymerase promoter. The expression plasmid
was introduced into E. coli BL21(DE3), a strain that con- lane 7) and heparin agarose (Fig. 1A, lane 8) column
chromatography. We verified that the single polypeptidetains the T7 RNA polymerase gene under the control of
a lacUV5 promoter. Expression of the plasmid-encoded detected by SDS–PAGE was indeed E3 by subjecting it
to automated Edman sequencing after transferring theprotein was achieved by IPTG induction of T7 RNA poly-
merase. The extent of expression was gauged by SDS – protein from the SDS gel to a PVDF membrane. The ex-
perimentally determined sequence—SKIYIDERSDA —PAGE analysis of unfractionated bacterial extracts. A 27-
kDa polypeptide corresponding to recombinant E3 accu- corresponded exactly to residues 2–12 of the predicted
E3 gene product; apparently, the recombinant proteinmulated to very high levels in extracts of IPTG-induced
bacteria (Fig. 1A, lane 2). Much lower amounts of E3 suffered removal of the initiating methionine. Further
characterization of recombinant E3 was performed usingprotein were observed in extracts of uninduced bacteria
(Fig. 1A, lane 1). This polypeptide was not evident in the heparin agarose preparation, which was homoge-
neous with respect to the E3 polypeptide.extracts of E. coli BL21(DE3) bearing the parent pET plas-
mid (not shown). It is worth pointing out that the recombinant E3 mi-
grated during SDS–PAGE on a 15% polyacrylamide gelThe majority of the expressed E3 protein was recov-
ered in the pellet fraction after crude bacterial lysates as a 27-kDa polypeptide, a value greater than the size
of 21.5 kDa predicted for the 190-amino acid product ofwere subjected to centrifugation (Fig. 1A, lane 4). A minor
fraction of E3 was recovered in the supernatant (Fig. 1A, the vaccinia E3 gene. Analysis of the purified E3 protein
by matrix assisted laser desorption ionization mass spec-lane 3) and was amenable to purification from the soluble
lysate by ion-exchange and RNA-affinity chromatography trometry (performed by S. Geromanos at the Sloan–Ket-
tering Microchemistry Core Facility) indicated a mass of(data not shown). A simpler purification procedure with
higher yield was developed after we determined that the 21.5 kDa. Hence, we need not invoke extensive covalent
modification of the E3 protein to explain the electropho-E3 protein could be solubilized from the pellet fraction
by treatment with NaCl. A 0.5 M NaCl extract of the pellet retic anomaly. Others have reported that E3 protein trans-
lated in vitro or isolated from virus-infected cells migratesfraction was highly enriched for E3; the only contaminant
of note was a 14-kDa species corresponding to lysozyme at 25 kDa during SDS–PAGE (Watson et al., 1991).
E3 binding to poly(rI)–poly(rC). An initial test of the(Fig. 1A, lane 5). Reextraction of the 0.5 M NaCl pellet with
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an ill-defined smear of slower electrophoretic mobility
compared to free RNA. The progressive slowing of the
mobility of the complexes as the E3 concentration was
increased suggested that multiple E3 molecules were
binding to the dsRNA. Binding appeared to saturate at
E3 concentrations 80 nM, at which point the bound
RNA migrated as a single shifted band (Fig. 2A). Note
that this species migrates into the native gel and does
not represent an aggregate in the sample well. (This is
more apparent in Fig. 2B, where the well is visible in the
autoradiogram.) In order to estimate binding affinity, the
gel in Fig. 2A was scanned using a phosphorimager and
the fraction of unbound RNA (expressed as % of the total
RNA) was plotted as a function of the concentration of
input E3 protein. RNA binding was proportional to E3
concentration up to 20 nM (data not shown); the apparent
dissociation constant, calculated according to Riggs et
al. (1970), was 7 nM.
The binding of E3 to the labeled 39-mer dsRNA was
competed in a concentration-dependent manner by unla-
beled poly(rI)–poly(rC) (Fig. 2B). Low amounts of dsRNA
competitor caused a progressive increases in the mobil-
ity of the complexes containing labeled dsRNA, consis-
tent with the sequential loss of E3 protomers from com-
plexes containing many molecules of E3 (and perhapsFIG. 2. Mobility shift assay of E3 binding to dsRNA. (A) Binding
multiple molecules of RNA as well). Also apparent wasreaction mixtures containing the indicated concentrations of E3 (hepa-
rin agarose fraction) were analyzed by electrophoresis through a native a super-shift of some of the labeled 39-mer dsRNA to
polyacrylamide gel. An autoradiogram of the dried gel is shown. The more slowly migrating forms, including a species that
positions of the unbound 32P-labeled dsRNA ligand and the shifted remained in the sample well. No such species were de-
protein–RNA complexes are indicated on the left. (B) Binding reaction
tected in reactions lacking competitor and this materialmixtures contained 2 nM 32P-labeled dsRNA, 200 nM E3, and increasing
was eliminated as competitor concentration was in-concentrations of unlabeled poly(rI)–poly(rC) (1, 2, 10, 50, 100, and 200
mg/ml, proceeding from left to right in the titration series). Competitor creased (Fig. 2B). We suggest that the supershifted spe-
was included in the reaction mixtures prior to the addition of protein. cies represent higher order complexes containing E3,
Samples were analyzed by native gel electrophoresis. An autoradio- 39-mer dsRNA, and the high-molecular weight poly(rI) –
gram of the dried gel is shown.
poly(rC) polymer. Higher concentrations of competitor
eliminated all binding to the 39-mer.
Nucleic acid binding specificity. Different nucleic acidsRNA binding properties of recombinant E3 protein was
its ability to bind to poly(rI)–poly(rC) agarose. E3 was were tested for their ability to compete with the labeled
39-mer dsRNA for binding to E3. Each unlabeled nucleicadsorbed quantitatively to the dsRNA column and was
refractory to elution with salt up to 1.5 M NaCl (Fig. 1B). acid was added at 100 mg/ml, a concentration sufficient
to cause complete inhibition of binding by poly(rI) –Although some E3 was released at 2 M NaCl, the bulk of
the bound protein could only be eluted under denaturing poly(rC) (Fig. 3). No inhibition of binding was elicited by a
single-stranded 60-mer DNA oligonucleotide, by double-conditions, i.e., in 1% SDS (Fig. 1B). Hence we conclude
that recombinant E3 bound tightly to dsRNA. stranded pUC19 DNA, or by single-stranded poly(rC).
However, the increased mobility of the labeled RNA –E3 binding to dsRNA in solution. A more informative
assay for dsRNA binding employed a defined radiola- protein complexes in the presence of poly(rI) suggested
that the latter competed weakly for binding to E3. Thesebeled ligand formed by annealing two partially comple-
mentary RNA strands that had been transcribed in vitro results underscore the high degree of specificity for the
binding of E3 to dsRNA in solution.by phage RNA polymerases. Treatment of the annealed
RNA with RNase A served to eliminate the unhybridized Oligomerization of E3 in solution. The native structure
of recombinant E3 was analyzed by glycerol gradientportions of the component strands, leaving a 39-bp RNA
duplex. Incubation of this dsRNA with recombinant E3 sedimentation. Internal standards (catalase, BSA, and cy-
tochrome C) were included in the same gradient with E3resulted in the formation of protein–RNA complexes that
were separated from the free dsRNA during native gel to facilitate accurate determination of its sedimentation
coefficient. In a 15–30% glycerol gradient containing 0.5electrophoresis (Fig. 2A). The bound RNA appeared as
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toward the top of the gradient (Fig. 4, bottom); an S value
of 3 was estimated at 1 M NaCl.
A plot of the data reveals an inverse relationship be-
tween sedimentation coefficient and NaCl concentration
in the range of 0.1 to 1 M (Fig. 5). The most straightfor-
ward explanation is that E3 self-associates to form higher
order oligomers, and that the extent of oligomerization
is governed by ionic strength. We have not performed
gel filtration analysis at salt concentrations other than
0.5 M; hence the average oligomer number at lower salt
concentrations cannot be gauged, beyond the obvious
conclusion that such complexes are larger than the puta-
tive trimer observed at 0.5 M NaCl. The S value ap-
proaches a lower limit at 1 M NaCl (Fig. 5). Taking the
0.5 M NaCl ‘‘trimer’’ as a benchmark, we suggest that E3
is likely to be a dimer at 1 M NaCl.FIG. 3. Nucleic acid binding specificity. Reaction mixtures (10 ml)
contained 2 pmol of E3, 20 fmol of 32P-labeled dsRNA, and unlabeled
nucleic acid as indicated (each at 100 mg/ml). Competitor nucleic acids
were included prior to addition of protein. Poly(rI), poly(rC), and poly(rI)–
poly(rC) were purchased from Pharmacia. ssDNA refers to a 60-mer
DNA oligonucleotide prepared by automated DMT–cyanoethyl phos-
phoramidite chemistry. pUC19 supercoiled plasmid DNA was prepared
by alkaline lysis and cesium chloride density gradient centrifugation.
An autoradiogram of the native gel is shown.
M NaCl, E3 sedimented as a discrete symmetrical com-
ponent of 4.2 S, slightly behind the BSA standard (Fig. 4,
middle panel). This value was not in keeping with a 21-
kDa monomeric structure for E3 under these solution
conditions. Gel filtration analysis of E3 in 0.5 M NaCl
was performed on a Waters Protein Pak 300SW column,
with catalase, yeast alcohol dehydrogenase, BSA, and
cytochrome C included as internal markers (data not
shown). A Stokes radius of 39 A was determined for E3
from a plot of (0Log Kav)0.5 versus Stokes radius of the
markers (Siegel and Monty, 1966). A molecular weight of
68,000 was calculated from the sedimentation coefficient
and Stokes radius values (Siegel and Monty, 1966). This
suggests that, on average, E3 behaved as a trimer in
solution at 0.5 M NaCl. However, the data do not reveal
whether E3 is a uniform population of E3 trimers or a
mixed distribution of E3 multimers around a mean of 3.
The sedimentation properties of E3 were examined at
several other concentrations of NaCl. In these experi-
ments, the concentration of E3 in the input sample was
kept constant at 0.25 mg/ml. Lowering the salt to 0.2 M
NaCl clearly increased the sedimentation coefficient of
FIG. 4. Sedimentation analysis. Purified E3 (50 mg) was mixed withE3, which can be appreciated immediately by the posi-
50 mg each of catalase, BSA, and cytochrome C in a final volume of
tion of E3 relative to BSA (Fig. 4, top). The peak fraction 0.2 ml of buffer A containing 0.2, 0.5, or 1.0 M NaCl. Samples were
of E3 sedimented at 7.4 S; slight asymmetry of the E3 layered onto 4.8-ml 15–30% glycerol gradients in buffer A containing
0.2 (top), 0.5 (middle), or 1.0 M NaCl (bottom). The gradients wereprofile toward the lighter side of the peak indicated some
centrifuged at 47 in a Beckman SW55 rotor at 55,000 rpm for either 12heterogeneity in the oligomerization state. At 0.1 M NaCl,
or 16 hr. Fractions (0.18 ml) were collected from the bottom of the
E3 sedimented even faster, with an S value of 9.3 (not tube. Aliquots of every other fraction were analyzed by SDS–PAGE;
shown). Increasing the salt concentration to 1 M NaCl polypeptides were visualized by staining with Coomassie blue dye.
The direction of sedimentation is from right to left.narrowed the peak and shifted the sedimentation profile
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0.05% glutaraldehyde. Hence, we conclude that the E3
protein is a dimer in solution at 1 M NaCl.
Crosslinking experiments performed at 0.1 M NaCl
yielded dramatically different results (Fig. 6, bottom).
Dimer and higher order multimer forms were readily
apparent at glutaraldehyde concentrations (0.001 –
0.002%) at which the bulk of the input E3 protein was
not modified. The ladder of species within the high-
molecular-weight array was consistent with formation
of hexamers up to dodecamers. Near-quantitative con-
version to E3 multimers occurred at 0.01% glutaralde-
hyde; this contrasts with the situation at 1 M NaCl, in
which the same concentration of glutaraldehyde elic-
ited only dimer formation. These crosslinking studies
confirm the conclusions of the sedimentation analysis
FIG. 5. Dependence of sedimentation coefficient on NaCl concentra-
tion. The sedimentation coefficient of E3 at 0.1, 0.2, 0.5, and 1 M NaCl
was determined by extrapolation of the peak fraction of E3 to a linear
plot of the peak fractions of the three internal standards (catalase, BSA,
cytochrome C). S value is plotted as a function of NaCl concentration.
With NaCl concentration held constant at 0.5 M, the
observed S value was affected by the concentration of
E3 in the protein sample. At an input concentration of 50
mg/ml, E3 sedimented as a discrete peak at 3.3 S (not
shown), compared with a 4.2 S at 0.25 mg/ml. A de-
creased sedimentation coefficient on sample dilution
provides additional evidence for a dynamic equilibrium
of E3 association and dissociation. A linear plot of S
versus protein concentration intercepted the y-axis at an
S value of 3, which can be taken as the lower limit of S
at infinite dilution in 0.5 M NaCl.
Formation of crosslinked E3 dimers in solution. Puri-
fied E3 was incubated with the bifunctional crosslink-
ing agent glutaraldehyde in buffer containing 1 M NaCl.
SDS – PAGE analysis showed that the electrophoretic
mobility of the E3 protein was altered as a function of
glutaraldehyde concentration (Fig. 6, top). Intramolecu-
lar crosslinking resulted in an increase in the electro-
phoretic mobility of the E3 polypeptide from 27 to 22
kDa (species denoted by an asterisk in Fig. 6, top) —
the latter value being more in keeping with the pre-
FIG. 6. Chemical crosslinking of E3 in solution. Reaction mixturesdicted size of the E3 gene product. Intermolecular
(20 ml) containing 5 mg of purified E3 in 25 mM sodium phosphate, pH
crosslinking was evidenced by the formation of dimers 7.4, either 1 M NaCl (top) or 0.1 M NaCl (bottom), and glutaraldehyde
migrating at 46 – 48 kDa. The mobility of the cross- (Aldrich) at the concentrations indicated (% v/v) were incubated for 30
min at room temperature. The samples were denatured in 2% SDS andlinked dimers shifted slightly as the glutaraldehyde
analyzed by SDS–PAGE (15% polyacrylamide gel). Polypeptides wereconcentration was increased, consistent with the for-
stained with Coomassie blue dye. The positions and sizes (in kDa) ofmation of intramolecular crosslinks within the E3 dimer
marker protein are indicated on the left. The species corresponding
unit. Dimer formation was nearly quantitative at 0.02% to unmodified E3 monomer, intramolecularly crosslinked E3 monomer
glutaraldehyde (Fig. 6). There was little formation of (asterisk), and intermolecularly crosslinked E3 dimers, trimers, and
multimers are indicated on the right.higher molecular weight crosslinked species, even at
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havior of the full-length E3 protein, we are reluctant to
attribute significance to the relative mobilities of the tryp-
tic peptides.) T3 and T4 were largely resistant to diges-
tion at trypsin levels in excess of that required to cleave
all the input E3. Peptide sequencing showed that T3 was
a mixture of two peptides, one retaining the N-terminus
of E3 and another derived by nearby cleavage at Lys-3/
Ile-4. T4 also consisted of a mixture of two peptides,
one from cleavage at Arg-95/Glu-96, and another from
cleavage at Lys-3/Ile-4.
These findings suggest that the E3 protein consists of
two trypsin-resistant structural domains separated by a
protease-sensitive interdomain bridge (Fig. 7). The bridge
is defined by the two trypsin-accessible peptide bonds
in the ‘‘middle’’ of the protein. A third exposed tryptic site
is situated close to the N-terminus. The domain repre-
sented by the 11-kDa carboxyl tryptic fragment includes
the conserved dsRNA binding motif (Fig. 7). Although we
suspect based on its size that this tryptic fragment ex-
tends from the bridge region to a position at or close to
the C-terminus of the protein, the available data do not
actually address the identity of the C-terminal residue.
Similar caveats apply to the downstream margins of the
amino fragment.FIG. 7. Partial proteolysis with trypsin. Reaction mixtures (20 ml)
containing 5 mg of purified E3 in 50 mM Tris HCl, pH 8.0, 0.4 M NaCl, Expression and characterization of the C-terminal
2.5% glycerol, and the indicated amount (ng) of trypsin were incubated RNA-binding domain. To examine the structure and func-
for 15 min at room temperature. The samples were denatured in 2% tion of the C-terminal domain per se, we constructed a
SDS and analyzed by SDS–PAGE (15% polyacrylamide gel). Polypep-
pET-based expression vector in which a segment of thetides were stained with Coomassie blue dye. The species correspond-
E3 protein from residues 100–190 was placed under theing to full-sized E3, and tryptic peptides T1, T2, T3, and T4, are denoted
by arrowheads. The positions and sizes (in kDa) of marker protein are control of a T7 promoter. Initial experiments indicated
indicated on the right. A schematic illustration of the bipartite domain that expression of the C-terminal domain of E3 was toxic
structure of the E3 protein is shown below the gel. The sites of tryptic to E. coli, i.e., we could not recover ampicillin resistant
cleavage, defined by the N-termini of the proteolytic products, are indi-
transformants when this plasmid was introduced into E.cated by arrowheads. The location of conserved dsRNA binding motif
coli BL21(DE3), a strain that contains the T7 RNA poly-(dsRBM) within the C-terminal domain of E3 is shown as a shaded
box. merase gene. The same plasmid readily transformed E.
coli BL21, the parent strain lacking the T7 RNA polymer-
ase gene. Note that this problem did not arise with T7-
based expression vectors containing the full-length E3that E3 dimers associate to form multimers as ionic
strength is reduced. gene. In order to circumvent the toxicity of E3(100–190),
we transferred the E3(100–190) coding region into aAnalysis of E3 domain structure by limited proteolysis.
Purified E3 was subjected to proteolysis with increasing pET21d vector background, such that the basal level of
E3(100–190) expression would be repressed by a lacamounts of trypsin. Although the sequence of the E3
protein indicates 29 potential sites for trypsin cleavage, operator element flanking the T7 promoter. This maneu-
ver permitted transformation of the plasmid intoinitial proteolytic attack on native E3 yielded two promi-
nent polypeptide fragments, referred to as T1 and T2 (Fig. BL21(DE3). To facilitate purification, the E3(100–190) pro-
tein was expressed as a fusion protein containing an7). Sequencing of these cleavage products by automated
Edman chemistry after transfer to a PVDF membrane amino-terminal leader peptide with 6 tandem histidines
(His–tag).revealed that T1 originated from the amino-terminus of
the recombinant E3 protein. T2 was a mixture of two Expression and initial fractionation of the C-terminal
E3 domain were carried out as described for the full-peptides arising from closely spaced tryptic cleavages
at peptide bonds Lys-92/Ser-93 and Arg-95/Glu-96. Two length E3 protein. An 11.5-kDa polypeptide correspond-
ing to E3(100–190) was recovered in the insoluble pelletadditional peptides were generated as the trypsin con-
centration was increased; these species, referred to as fraction of lysates of IPTG-induced bacteria (not shown).
This protein could be partially solubilized by extractionT3 and T4, migrated between T1 and T2 during SDS –
PAGE (Fig. 7). (Given the anomalous electrophoretic be- of the pellet with 1 M NaCl (Fig. 8A, lane 1). The His-
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FIG. 8. Purification and chemical crosslinking of E3(100–190). (A) Ni–agarose affinity chromatography was performed as described under Materials
and Methods. Aliquots of the 1 M NaCl extract of the pellet fraction of the bacterial lysate (lane 1); the Ni–agarose unbound (lane 2) and wash
(lane 3) fractions; and the 50 mM imidazole (lane 4), 100 mM imidazole (lane 5), and 500 mM imidazole (lane 6) eluate fractions were analyzed by
SDS –PAGE (15% polyacrylamide gel). Polypeptides were stained with Coomassie blue dye. The species corresponding to the His-tagged E3(100–
190) protein is indicated by an arrowhead. The positions and sizes (in kDa) of marker proteins are indicated on the left. (B) Crosslinking reaction
mixtures (20 ml) containing 25 mM sodium phosphate, pH 7.4, 5 mg of purified E3(100–190), 1 M NaCl, and glutaraldehyde at the concentrations
indicated (% v/v) were incubated for 30 min at room temperature. The samples were denatured in 2% SDS and analyzed by SDS–PAGE (15%
polyacrylamide gel). Polypeptides were stained with Coomassie blue dye. The positions and sizes (in kDa) of marker protein are indicated on the
left. The species corresponding to unmodified E3(100–190) monomer and crosslinked E3(100–190) dimer are indicated on the right.
tagged polypeptide was then adsorbed to a Ni–NTA complexes with regular ladder-like spacing were evident
at 1 to 5 nM protein (Fig. 9). The evolution of the ladderagarose column and eluted with 500 mM imidazole, at
which stage the preparation was essentially homoge- of complexes with protein concentration suggested se-
quential binding of E3(100–190) protomers to singleneous (Fig. 8A, lane 6). The ability of E3(100–190) to
bind to dsRNA was verified by poly(rI)–poly(rC) agarose RNAs. The observation that multiple proteins were bound
well before all the input ligand had been shifted indicatedchromatography. E3(100–190) bound to the resin and
could not be eluted except by denaturation with SDS that E3(100–190) might be binding cooperatively to the
dsRNA. A distinct population of complexes was formed(data not shown).
Sedimentation and crosslinking analysis of the RNA that did not migrate into the gel, but remained instead
near the sample well. The appearance of these com-binding domain. Purified E3(100–190) was subjected to
glycerol gradient sedimentation as described above for plexes as a function of protein concentration lagged be-
the full-length protein. An S value of 2.4 was determined
relative to internal standards when sedimentation was
performed at 1 M NaCl (data not shown). Unlike the full-
length E3 protein, the sedimentation coefficient of
E3(100–190) did not change when the ionic strength was
reduced to 0.2 M NaCl (not shown). Incubation of
E3(100–190) with glutaraldehyde resulted in the forma-
tion of crosslinked dimers migrating at 24–27 kDa dur-
ing SDS–PAGE (Fig. 8B). There was scant formation of
higher molecular weight crosslinked species, even at
0.05% glutaraldehyde. The same crosslinking pattern
was observed when the experiment was performed in
buffer containing 0.2 M NaCl (data not shown). Hence,
we conclude that the C-terminal RNA binding domain is
a dimer in solution and that its oligomerization state is
salt-independent.
FIG. 9. Binding of E3(100–190) to dsRNA. Reaction mixtures (10 ml)dsRNA binding by E3(100–190). The binding of
containing 2 nM 32P-labeled dsRNA and E3(100–190) protein as speci-E3(100–190) to the 39-mer dsRNA ligand in solution was
fied were incubated for 15 min at 257. Protein–RNA complexes wereassessed using the gel mobility shift assay. The RNA –
resolved from free RNA by electrophoresis through a native 4% poly-
protein complexes formed by E3(100–190) at 1 to 5 nM acrylamide gel. An autoradiogram of the gel is shown. The positions
input protein were more discrete and better resolved of the unbound 32P-labeled RNA ligand, the shifted protein–RNA com-
plexes, and the sample well are indicated on the left.than those seen with the full-length E3. Three to four
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FIG. 10. Nucleic acid binding specificity of E3(100–190). Binding reaction mixtures contained 2 nM of 32P-labeled RNA–RNA duplex (A), RNA–
DNA hybrid (B), or DNA–DNA duplex (C) and either 2, 5, 10, 20, or 50 nM of purified E3(100–190) (from left to right within each titration series).
Protein–nucleic acid complexes were resolved from free nucleic acid by electrophoresis through a native 4% polyacrylamide gel. An autoradiogram
of the gel is shown. The positions of the unbound 32P-labeled probe and the sample well are indicated on the left. The ligands consisted of a 34-
bp duplex region with 19-nt and 11-nt 5* tails and a 19-nt 3* tail, as illustrated. The [a32P]GMP-labeled 45-mer bottom RNA strand (5*-GGGCGAAUU-
GGAUCGAAUUCCUGCAGCCCGGGGGAUCCACUAGUU-3*) was transcribed in vitro by T7 RNA polymerase at high specific radioactivity from a
modified pBluescript template. The 72-mer top RNA strand (5*-GGGAACAAAAGCUGGCUAGAACUAGUGGAUCCCCCGGGCUGCAGGAAUUCGAU-
AUCAAGCUUAUCGAUACCG-3*) was synthesized by T3 RNA polymerase from a modified pBluescript template and was labeled at 300-fold lower
specific activity. The duplex region is underlined. DNA strands of identical sequence (with T in place of U) were prepared by automated DMT–
cyanoethyl phosphoramidite chemistry. The 45-mer DNA bottom strand in the RNA–DNA hybrid and the DNA–DNA duplex was 5* end-labeled
with [g32P]ATP using T4 polynucleotide kinase. Annealing of the component strands and gel purification of the duplexes prior to use in binding
assays was carried out as described (Gross and Shuman, 1995).
hind that of the ladder, but preceded the binding of all the tailed RNA–RNA molecule with affinity similar to that
observed for the 39-mer; about half the input probe wasinput dsRNA (Fig. 9). It is likely that the species in the
sample well represented higher order complexes con- shifted at 10 nM protein. A diffuse smear of shifted RNA
present at low protein concentrations evolved at highertaining multiple dsRNA molecules bound to protein. All
input ligand was shifted to the well at a protein concen- levels of protein to complexes that migrated near the
sample well (Fig. 10A). Neither the RNA–DNA hybrid (Fig.tration greater than 20 nM. The gel in Fig. 9 was scanned
using a phosphorimager and the fraction of unbound 10B) nor the DNA–DNA duplex (Fig. 10C) was bound to
any significant extent (as gauged by diminution of freeRNA (expressed as percentage of the total RNA) was
plotted as a function of the concentration of input probe or by shift to the sample well) by E3(100–190) at
up to 50 nM concentration, a level sufficient to bind theE3(100–190) (not shown); the apparent dissociation con-
stant was 9 nM, a value comparable to that of the full- RNA–RNA ligand quantitatively. We conclude that vac-
cinia E3 can discriminate an RNA–RNA duplex from anlength E3 protein.
Competition experiments presented earlier suggested RNA–DNA hybrid.
that E3 bound specifically to dsRNA, but not to dsDNA
(Fig. 3). We examine the binding specificity of E3(100 – DISCUSSION
190) by directly comparing its binding to synthetic RNA –
RNA and DNA–DNA duplexes, and to an RNA–DNA hy- The E3 protein is a key component of the ‘‘anti-antiviral’’
response mounted by vaccinia virus in the face of hostbrid. The ligands were constructed using DNA oligonu-
cleotides prepared by automated synthesis and RNAs efforts to abort or limit virus infection. E3 mitigates the
antiviral effects of interferon by blocking cellular re-transcribed in vitro by bacteriophage RNA polymerase.
Annealing a 72-mer top strand to a 45-mer bottom strand sponse pathways dependent on double-stranded RNA.
Genetic experiments suggest that the biological activityyielded a 34-bp duplex molecule with single-stranded
tails as shown in Fig. 10. The sequences of the compo- of E3 is intimately linked to its ability to bind and seques-
ter dsRNA within the infected cell. Insights into the struc-nent strands were the same in the RNA–DNA, DNA–
RNA, and DNA–DNA substrates. E3(100–190) bound to ture and RNA binding properties of the E3 protein have
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come largely from the analysis of radiolabeled translation apparently not susceptible to limited proteolysis in the
native E3 protein. That the C-terminal domain per seproducts. In this paper, we present an analysis of the
physical and function properties of recombinant E3 pro- binds to dsRNA was verified by studies of recombinant
E3(100–190) purified from bacteria. The affinity of the C-tein purified to homogeneity from bacteria. Our findings
confirm the dsRNA binding properties previously attrib- terminal domain for the 39-mer dsRNA ligand was com-
parable to that of the full-length E3 protein.uted to E3, while extending the analysis to include a
quantitative and qualitative assessment of the complexes The resolution of individual protein–RNA complexes
by native gel electrophoresis was better for E3(100–190)formed between E3 and a defined dsRNA ligand. We
provide new insights into the domain structure of E3, than for the full-length E3 protein. Sequential formation
of a ladder of RNA-E3(100–190) complexes at low proteindemonstrate for the first time that E3 is a dimer, and
document the previously unappreciated property of E3 concentrations suggested that binding to the 39-mer RNA
was cooperative. Assuming that the ladder representsself-association to form higher order oligomers in solu-
tion. complexes containing one RNA molecule with varying
amounts of bound protein, we estimate that four E3(100–Prior work had shown that metabolically labeled E3
bound to poly(rI)–poly(rC) immobilized on an agarose 190) ‘‘units’’ could be bound to the 39-mer RNA. The
stoichiometry of protein and RNA within the complexesmatrix (Chang and Jacobs, 1993). In this technique, the
RNA ligand consists of high-molecular-weight homopoly- that compose the ladder is not revealed by the available
data; hence we cannot judge whether E(100–190) bindsmers of heterogeneous chain length. The true concentra-
tions of dsRNA and E3 protein are not known; it is there- to the dsRNA in monomeric or dimeric step increments.
However, the dimeric structure of E3(100–190) in solu-fore difficult to accurately quantitate binding affinity. Be-
cause the relative amount of bound protein is assessed tion suggests that it binds as a dimer to dsRNA.
The specificity of the C-terminal RNA binding domainafter elution with SDS, there is little sense of the nature
of the RNA–protein complexes formed. The use of a is such that it discriminates clearly between a dsRNA
structure, to which it binds with high affinity, and dsRNAnative gel mobility shift assay and a defined RNA ligand
of smaller size has shed some light on these issues. We and RNA–DNA hybrid structures, to which it appears not
to bind at all, at least not at protein concentrations up tohave shown that E3 binds in solution to a 39-bp dsRNA
ligand with a dissociation constant of about 10 nM. Multi- 50 nM. The RNA–DNA hybrid result is especially informa-
tive, because it suggests that E3 strictly recognizes anple E3 protomers appear to bind sequentially to the
dsRNA. The tendency of E3 to oligomerize at low ionic A-form helical conformation. X-ray fiber diffraction and
NMR studies indicate that although DNA–RNA hybridsstrength raises the possibility that E3 protomers may
join the dsRNA–protein complexes by virtue of protein– have substantial A-form character, their structure differs
from that of pure A-form dsRNA (Arnott et al., 1986; Sala-protein interactions as well as by direct contact with the
dsRNA. E3 protomers associated with one RNA–protein zar et al., 1993). The RNA and DNA chains adopt different
helical conformations within the DNA–RNA hybrid, withcomplex might be expected to interact with E3 molecules
in another protein–RNA complex; this phenomenon is the RNA strand retaining the A-form helical conformation
(as found in dsRNA) while the DNA strand adopts confor-likely to account for the formation of the most severely
retarded RNA–protein complexes detected at high pro- mation that is neither strictly A nor B, but is instead
intermediate in character between these two forms. Fail-tein concentrations. The specificity of E3 binding to
dsRNA in solution was confirmed by competition experi- ure of E3(100–190) to form a complex on the RNA–DNA
hybrid in the gel-shift assay suggests that either the pro-ments. Our results agree with earlier findings that the
binding of labeled E3 to poly(rI)–poly(rC) agarose was tein cannot bind to structures that deviate from the A-
form helix or complexes formed on such molecules arecompeted by soluble poly(rI)–poly(rC) and reovirus
dsRNA, but not by poly(C), native DNA, or denatured DNA not stable enough to survive native gel electrophoresis.
A distinctive property of the full-length E3 protein is(Chang and Jacobs, 1993). We noted that poly(rI) was a
weak competitor of E3 binding to dsRNA. its inherent ability to oligomerize in solution. The extent
of oligomerization at equilibrium is governed by solutionIt had been shown previously that the C-terminal half
of the E3 protein translated in vitro was sufficient to bind conditions, particularly ionic strength. Sedimentation
analysis suggests that the native form of E3 at 1 M NaCldsRNA. We now show that the C-terminal half of the E3
protein constitutes a trypsin-resistant structural domain, is likely to be a dimer. This is supported by the formation
of crosslinked E3 dimers upon incubation with glutaral-separated from a second N-terminal domain by a trypsin-
sensitive interdomain bridge. According to computer- dehyde. We estimated from gel filtration and sedimenta-
tion data that E3 behaves, on average, as a trimer atgenerated hydrophilicity predictions, the sites of trypsin
cleavage at Lys-92 and Arg-95 fall within a hydrophilic 0.5 M NaCl. We suspect that this reflects a mixture of
dimers and tetramers rather than a pure population ofregion with high surface probability. Other predicted hy-
drophilic regions containing potential tryptic sites were E3 trimers. An increase in the extent of oligomerization
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occurred as NaCl concentration was decreased below infection of an animal host that cannot be discerned at
the level of virus infection in cell culture.0.5 M NaCl. At 0.1 M NaCl, crosslinked complexes con-
tained as many as 6 to 12 E3 subunits. A native size for How do the properties of vaccinia E3 compare to those
of other proteins that bind to dsRNA? The affinity of E3E3 of 66 kDa had been determined previously on the
basis of gel filtration of an S100 fraction in buffer con- and E3(100–190) for the 39-mer dsRNA is similar to that
reported for the binding of partially purified PKR to adeno-taining 150 mM KCl (Watson et al., 1991). The oligomer-
ization state of E3 in the S100 fraction at 150 mM salt virus VA RNA (KD  2 nM) (McCormack and Samuel,
1995). A 243-amino-acid N-terminal RNA binding domainis less than what we would predict based on sedimenta-
tion results presented here. However, it should be kept of PKR (which includes two copies of the dsRNA binding
motif present in one copy in E3) bound VA RNA with thein mind that the oligomerization state is dependent on
protein concentration and it is likely that the concentra- same affinity as full-sized PKR (McCormack and Samuel,
1995). A 184-amino-acid N-terminal fragment of PKR con-tion of E3 in the S100 was less than that of the recombi-
nant E3 protein (0.25 mg/ml) used in the present sedi- taining both dsRNA binding motifs bound an 85-bp
dsRNA and with a dissociation constant of 4 nMmentation experiments.
The C-terminal dsRNA binding domain of E3 conspicu- (Schmedt et al., 1995). However, a recombinant N-termi-
nal 91-amino acid segment containing only the firstously lacks the capacity for salt-dependent oligomeriza-
tion, as judged by the lack of variation in sedimentation dsRNA binding motif bound the 85-mer dsRNA with 100-
fold lower affinity (Schmedt et al., 1995). It makes sensecoefficient as a function on NaCl concentration. A simple
interpretation is that the N-terminal domain is required that E3 would bind dsRNA with an affinity near that of
PKR, given that a key function of E3 in vivo is to sequesterfor salt-dependent oligomerization of E3. What is the sig-
nificance, if any, of the ability to oligomerize in this way? dsRNA so that it cannot bind to and activate PKR. What
is striking is that E3 achieves this binding affinity with aThe finding that a transfected E3 mutant lacking the N-
terminus could still complement the host range pheno- single copy of the dsRNA binding motif, whereas PKR
clearly requires two copies. Because E3 is apparently atype of an E3-deletion virus and reverse interferon inhibi-
tion of viral protein synthesis suggests that the N-termi- dimer in the native state, it is possible that each monomer
contributes one copy of the motif to form a high affinitynal domain is dispensable for E3 function in vivo (Chang
et al., 1995). Yet, the presence of the N-terminal domain dsRNA binding pocket. Especially tight affinity for dsRNA
is seen with the Xenopus 4F protein (KD  0.3 nM), whichimpacts profoundly on the intracellular distribution of E3.
Immunofluorescence studies demonstrate two popula- also contains two copies of the conserved dsRNA bind-
ing motif (Bass et al., 1994).tions of E3 within vaccinia-infected cells—one localized
to cytoplasmic viral factories and another within the cell
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